India’s drug regulator has approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute of India (SII) and to indigenously developed Covaxin of Bharat Biotech.
Share Bazaar News Today | Sensex, Nifty, Share Prices LIVE: Domestic equity benchmark indices were trading with gains on Monday. S&P BSE Sensex was up over 200 points sitting well beyond 48,000 for the first time in history. Nifty 50 too was at its all-time highs crossing 14,100 for the first time. Broader markets were outperforming benchmark indices on Monday morning. Nifty smallcap 50 was up 0.99% while Nifty midcap 50 was up 1.43%. TCS, ONGC, SBI and L&T were the top Sensex gainers. Shanghai Composite was trading flat with a positive bias while Hang Seng was up almost half a per cent. South Korean equity markets were also in the green with KOSPI zooming 1.161%, but TOPIX and Nikkei 225 were trading in red.
India has joined the list of countries that are aiming to reach back to the old normal faster than earlier anticipated as the country granted approval to two coronavirus vaccines yesterday. India’s drug regulator has approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute of India (SII) and to indigenously developed Covaxin of Bharat Biotech for restricted emergency use. SII’s vaccine, Covishield will be the primary vaccine that will be used while Covaxin will be kept for emergency use. Covaxin is still undergoing phase-3 trials.
–
